Vulnerabilities in coronavirus glycan shields despite extensive glycosylation

Vulnerabilities in coronavirus glycan shields despite extensive glycosylation

Severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) coronaviruses (CoVs) are zoonotic pathogens with high fatality rates and pandemic potential. Vaccine development focuses on the principal target of the neutralizing humoral immune response, the spike (S) glycoprotei...

Full description

Bibliographic Details
Main Authors:	Watanabe, Y, Berndsen, ZT, Raghwani, J, Seabright, GE, Allen, JD, Pybus, OG, McLellan, JS, Wilson, IA, Bowden, TA, Ward, AB, Crispin, M
Format:	Journal article
Language:	English
Published:	Springer Nature 2020

Similar Items

Vulnerabilities in coronavirus glycan shields despite extensive glycosylation
by: Yasunori Watanabe, et al.
Published: (2020-05-01)

Structure of the Lassa virus glycan shield provides a model for immunological resistance
by: Watanabe, Y, et al.
Published: (2018)

Antibodies expose multiple weaknesses in the glycan shield of HIV.
by: Crispin, M, et al.
Published: (2013)

Antibodies expose multiple weaknesses in the glycan shield of HIV.
by: Crispin, M, et al.
Published: (2013)

The impact of sequence diversity on the glycan shield of HIV-1 immunogens
by: Seabright, GE
Published: (2019)

Quantification of the Resilience and Vulnerability of HIV-1 Native Glycan Shield at Atomistic Detail
by: Srirupa Chakraborty, et al.
Published: (2020-12-01)

Glycan clustering stabilizes the mannose patch of HIV-1 and preserves vulnerability to broadly neutralizing antibodies.
by: Pritchard, L, et al.
Published: (2015)

Mapping the glycan shields of enveloped viruses
by: Watanabe, Y
Published: (2020)

Architecture of the HIV-1 glycan shield
by: Pritchard, L
Published: (2014)

Integrity of glycosylation processing of a glycan-depleted trimeric HIV-1 immunogen targeting key B-cell lineages
by: Behrens, AJ, et al.
Published: (2018)

The diversity of the glycan shield of sarbecoviruses related to SARS-CoV-2
by: Joel D. Allen, et al.
Published: (2023-04-01)

The glycan shield of HIV is predominantly oligomannose independently of production system or viral clade.
by: Bonomelli, C, et al.
Published: (2011)

Targeting Glycans and Heavily Glycosylated Proteins for Tumor Imaging
by: Ruben D. Houvast, et al.
Published: (2020-12-01)

Glycosylator: a Python framework for the rapid modeling of glycans
by: Thomas Lemmin, et al.
Published: (2019-10-01)

N- and O-glycan analysis for the detection of glycosylation disorders
by: Amr Sobhi Gouda, et al.
Published: (2021-01-01)

Immune recruitment or suppression by glycan engineering of endogenous and therapeutic antibodies
by: Le, N, et al.
Published: (2016)

The glycan shield of HIV is predominantly oligomannose independently of production system or viral clade.
by: Camille Bonomelli, et al.
Published: (2011-01-01)

Glycan shield of the ebolavirus envelope glycoprotein GP
by: Weiwei Peng, et al.
Published: (2022-08-01)

Fine structure of the HIV-1 glycan shield
by: Behrens, A
Published: (2017)

Arenavirus glycan shield promotes neutralizing antibody evasion and protracted infection.
by: Sommerstein, R, et al.
Published: (2015)

Glycan Nanostructures of Human Coronaviruses
by: Guo W, et al.
Published: (2021-07-01)

Arenavirus Glycan Shield Promotes Neutralizing Antibody Evasion and Protracted Infection.
by: Rami Sommerstein, et al.
Published: (2015-11-01)

Synthesis of N-glycan oxazolines: donors for endohexosaminidase catalysed glycosylation.
by: Rising, T, et al.
Published: (2006)

N-Glycosylation and N-Glycan Processing in HBV Biology and Pathogenesis
by: Mihaela-Olivia Dobrica, et al.
Published: (2020-06-01)

Glycosylation network mapping and site-specific glycan maturation in vivo
by: Marie-Estelle Losfeld, et al.
Published: (2022-11-01)

Recognition and penetration of the HIV-1 Env glycan shield by potent broadly neutralizing antibodies
by: Julien J, et al.
Published: (2012-09-01)

Glycan Positioning Impacts HIV-1 Env Glycan-Shield Density, Function, and Recognition by Antibodies
by: Qing Wei, et al.
Published: (2020-11-01)

Antibody evasion by a gammaherpesvirus O-glycan shield.
by: Bénédicte Machiels, et al.
Published: (2011-11-01)

Glycan Profile Analysis of Engineered Trastuzumab with Rationally Added Glycosylation Sequons Presents Significantly Increased Glycan Complexity
by: Esteban Cruz, et al.
Published: (2021-10-01)

Emerging COVID-19 coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26
by: Naveen Vankadari, et al.
Published: (2020-01-01)

A Potent and Broad Neutralizing Antibody Recognizes and Penetrates the HIV Glycan Shield
by: Pejchal, R, et al.
Published: (2011)

Fine structure of the HIV-1 glycan shield - Supplementary information
by: Behrens, A
Published: (2017)

Quantification of the Impact of the HIV-1-Glycan Shield on Antibody Elicitation
by: Tongqing Zhou, et al.
Published: (2017-04-01)

Glycan Shielding and Modulation of Hepatitis C Virus Neutralizing Antibodies
by: Muriel Lavie, et al.
Published: (2018-04-01)

Structural constraints determine the glycosylation of HIV-1 envelope trimers
by: Pritchard, L, et al.
Published: (2015)

Glycosylation Biomarkers Associated with Age-Related Diseases and Current Methods for Glycan Analysis
by: Beatrix Paton, et al.
Published: (2021-05-01)

Glycan heterogeneity as a cause of the persistent fraction in HIV-1 neutralization.
by: Rajesh P Ringe, et al.
Published: (2023-10-01)

Controlled site-selective protein glycosylation for precise glycan structure-catalytic activity relationships.
by: Davis, B, et al.
Published: (2000)

Genetic determinants of genus-level glycan diversity in a bacterial protein glycosylation system
by: Hadjineophytou, C, et al.
Published: (2019)

Extensive weight loss reduces glycan age by altering IgG N-glycosylation
by: Greto, VL, et al.
Published: (2021)